Expression of matrix metalloproteinases and related tissue inhibitors in the cyst fluids of ovarian mucinous neoplasms

Gynecologic Oncology

Volumn 78, Issue 2, 2000, Pages 106-112

  Furuya, Mitsuko ^a   Ishikura, Hiroshi ^a,b   Kawarada, You ^a   Ogawa, Yayoi ^a   Sakuragi, Noriaki ^a   Fujimoto, Seiichiro ^a   Yoshiki, Takashi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cystic fluid; Matrix metalloproteinase (MMP); Mucinous tumor; Ovary; Tissue inhibitor of metalloproteinase (TIMP); Trypsin

Indexed keywords

CASEIN; GELATIN; GELATINASE A; GELATINASE B; MATRILYSIN; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRYPSIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYST FLUID; CYSTADENOMA; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; ZYMOGRAPHY;

EID: 0033838376     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2000.5856     Document Type: Article

References (24)

1. Comparison of extracellular matrix-degrading activities between 64-kDa and 90-kDa gelatinases purified in inhibitor-free forms from human schwannoma cells
2. Matrix metalloproteinases and the development of cancer
3. The origin of matrix metalloproteinases and their familial relationships
4. Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library
5. Evaluation of basement membrane components and the 72-kDa type IV collagenase in serous tumors of the ovary
6. Expression of 72 kilodalton type IV collagenase (gelatinase A) in benign and malignant ovarian tumors
7. Characterization of matrix-degrading proteinases and their inhibitors secreted by human gynecological carcinoma cells
8. Secretion of extracellular matrix-degrading proteinases is increased in epithelial ovarian carcinoma
9. Characterization of gelatinases linked to extracellular matrix invasion in ovarian adenocarcinoma
10. Discovery of CGS27023A, a non-specific, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits
11. Cyst fluid of ovarian cancer patients contains high concentration of trypsinogen-2
12. Loss of basement membrane type IV collagen is associated with increased expression of metalloproteinases 2 and 9 (MMP-2 and MMP-9) during human colorectal tumorigenesis
13. Stromal expression of 72kda type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia
14. Expression of gelatinase A, tissue inhibitor of metalloproteinases-2, matrilysin, and trypsin(ogen) in lung neoplasms
15. Matrix metalloproteinase 7 (matrilysin) from human rectal carcinoma cells
16. Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1
17. The role of matrix metalloproteinases and their inhibitors in tumor invasion, metastasis and angiogenesis
18. Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases
19. Tumor cell invasion inhibited by TIMP-2
20. Human ovarian tumor-associated trypsin
21. Differential expression of trypsin in human ovarian carcinomas and low-malignant potential tumors
22. The precursor of a metalloendopeptidase from human rheumatoid synovial fibroblasts
23. Imbalance of expression of matrix metalloproteinases (MMPs) and tissue inhibitors of the matrix metalloproteinases (TIMPs) in human pancreatic carcinoma
24. Production of matrix matalloproteinase-2 and metalloproteinase-3 related to malignant behavior of esophageal carcinoma